Unique Francisella Phosphatidylethanolamine Acts as a Potent Anti-Inflammatory Lipid

Virulent Francisella tularensis subsp. tularensis (Ftt) is a dynamic, intracellular, bacterial pathogen. Its ability to evade and rapidly suppress host inflammatory responses is considered a key element for its profound virulence. We previously established that Ftt lipids play a role in inhibiting i...

Full description

Saved in:
Bibliographic Details
Published inJournal of innate immunity Vol. 10; no. 4; pp. 291 - 305
Main Authors Ireland, Robin, Schwarz, Benjamin, Nardone, Glenn, Wehrly, Tara D., Broeckling, Corey D., Chiramel, Abhilash I., Best, Sonja M., Bosio, Catharine M.
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 01.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Virulent Francisella tularensis subsp. tularensis (Ftt) is a dynamic, intracellular, bacterial pathogen. Its ability to evade and rapidly suppress host inflammatory responses is considered a key element for its profound virulence. We previously established that Ftt lipids play a role in inhibiting inflammation, but we did not determine the lipid species mediating this process. Here, we show that a unique, abundant, phosphatidylethanolamine (PE), present in Francisella, contributes to driving the suppression of inflammatory responses in human and mouse cells. Acyl chain lengths of this PE, C24: 0 and C10: 0, were key to the suppressive capabilities of Francisella PE. Addition of synthetic PE 24: 0–10: 0 resulted in the accumulation of PE in host cells for up to 24 h of incubation, and recapitulated the inhibition of inflammatory responses observed with native Ftt PE. Importantly, this novel PE significantly inhibited inflammatory responses driven by a medically and globally important flavivirus, dengue fever virus. Thus, targeting these lipids and/or the pathways that they manipulate represents a new strategy to combat immunosuppression engendered by Ftt, but they also show promise as a novel therapeutic intervention for significant viral infections.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
R.I., B.S., and C.M.B. contributed equally to this work.
ISSN:1662-811X
1662-8128
1662-8128
DOI:10.1159/000489504